March 1, 2022 -- Thermo Fisher Scientific is calling for new proposals for its Oncomine Clinical Research Grant. This builds on the company’s continuous work to support continued advancements and developments in the realm of clinical oncology research. The latest request for submissions from the global scientific community will award funding for molecular profiling research that helps accelerate the use of genomic sequencing in oncology.
Since launching the program in 2020, Thermo Fisher has awarded Oncomine Clinical Research Grants to 16 projects worldwide in support of research in hematology-oncology, immuno-oncology, liquid biopsy, and fusion gene detection. Recipients of the last funding round, which supported clinical research programs using NGS technology in solid tumors and hematology-oncology applications, included: